亚洲 · 通讯社与实时数据 · Focus Taiwan (CNA)
PharmaEssentia seeks to expand access to blood cancer drug in Europe
Taiwan-based drugmaker PharmaEssentia Corp. is seeking to expand patient access to its blood cancer drug Ropeg in Europe, where the treatment has yet to receive regulatory…
在 Focus Taiwan (CNA) 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (focustaiwan.tw)



